https://www.prnewswire.com/news-releases/cns-pharmaceuticals-announces-sponsored-research-agreement-with-md-anderson-for-potential-cancer-treatment-technologies-301066566.html
0
0
5/28/20 at 12:00pm
Organization
PRNewswire
Authors
HOUSTON, May 28, 2020 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system…
Create an account
or login to join the discussion